A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats.

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats. Abstract Text:

Tadashi Namisaki,Hitoshi Yoshiji,Shigeki Kuriyama,Hideyuki Kojima,Junichi Yoshii,Yasuhide Ikenaka,Ryuichi Noguchi,Shinya Sakurai,Koji Yanase,Mitsuteru Kitade,Masaharu Yamazaki,Kiyoshi Asada,Tatsuhiro Tsujimoto,Takemi Akahane,Masahito Uemura,Hiroshi Fukui,

Although it has been shown that a simultaneous administration of the vascular endothelial growth factor (VEGF); a potent angiogenic factor, could improve the overall survival of chemically induced acute hepatic failure (AHF) in rats, it has not been elucidated yet whether this salvage effect can be observed in the on-going AHF or not. For future clinical application, we examined the effect of VEGF on the on-going AHF. A combination of d-galactosamine (Gal-N) and lipopolysaccharide (LPS) was administered to induce AHF in rats. The survival rate and several indices were compared with or without VEGF treatment at 12 and 24h after the intoxication. Even after the establishment of severe liver injury, the overall survival and the serum ALT elevation were significantly improved by treatment with VEGF. The proliferation of the hepatocytes and sinusoidal endothelial cells (SEC) was also stimulated by VEGF. Furthermore, VEGF prevented the destruction of the architecture of the hepatic sinusoids. Since VEGF significantly improved the survival of the on-going AHF, the exogenous VEGF administration may represent a feasible new therapeutic strategy for AHF in the future.

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats. Publishing Authors By Initials

T Namisaki,H Yoshiji,S Kuriyama,H Kojima,J Yoshii,Y Ikenaka,R Noguchi,S Sakurai,K Yanase,M Kitade,M Yamazaki,K Asada,T Tsujimoto,T Akahane,M Uemura,H Fukui,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hepatology research : the official journal of the

VOLUME: 35

Page Numbers: 199-203

Journal Abbreviation:

ISSN: 1386-6346

DAY: 22

MONTH: 05

YEAR: 2006

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9711801

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats.

AFFILIATION: Third Department of Internal Medicine, Nara Medical University, Shijo-cho 840, Kashihara, Nara 634-8522, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats Related Publications

• 2-Geranyl-1,4-naphthoquinone, a possible intermediate of anthraquinones in a Sesamum indicum hairy root culture.
• A numerical simulation of orthodontic tooth movement produced by a canine retraction spring.
• A numerical simulation of tooth movement produced by molar uprighting spring.
• A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats.
• Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development.
• Aortic valve replacement in a patient with myelodysplastic syndrome and interstitial pneumonia.
• Blastocyst production by in vitro maturation and development of porcine oocytes in defined media following intracytoplasmic sperm injection.
• Construction and performance test of SGM-TRAIN at UVSOR.
• Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats.
• Diffusion-weighted imaging predicts postoperative persistence in meningioma patients with peritumoural abnormalities on magnetic resonance imaging.
• Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer.
• Effect of glucose levels during the in vitro culture in synthetic oviduct fluid medium on in vitro development of bovine oocytes matured and fertilized in vitro.
• Effects of quality and developmental stage on the survival of IVF-derived bovine blastocysts cultured in vitro after freezing and thawing.
• Eosinophilic cholecystitis as a rare manifestation of visceral larva migrans.
• Giant parapharyngeal space lipoma: case report and surgical approach.
• Ground based verification of JAXA hardware for life science experiments.
• Health locus of control and use of conventional and alternative care: a cohort study.
• Human D-amino acid oxidase: an update and review.
• Increased von Willebrand Factor Over Decreased ADAMTS13 Activity May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients With Alcoholic Hepatitis.
• Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
• Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis and direct anastomosis.
• Neurodegenerative disorders in schizophrenia.
• Obstinate cough as a sole presenting symptom of non-metastatic renal cell carcinoma.
• Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.
• Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases.
• Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor.
• Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma.
• T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2.
• The HNF-1alpha-SNARE connection.
• [Prostate cancer]